PIK3CD and B-cell chronic lymphocytic leukemia: In CLL, PI3K inhibitors (PI3Ki) disrupt the B-cell receptor signaling pathway, affecting cell adhesion and leukemic cell trafficking, thereby inducing apoptosis and cell death [131].